Our results showed that the Y68 frame shift mutation of the PTEN gene led to docetaxel drug resistance in chemotherapy of endometrial cancer cells by destroying the protein phosphatase and lipid phosphatase activities of PTEN. This evidence concerns the gene PTEN and endometrial cancer.